Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer.
Du X, Fei X, Wang J, Dong Y, Fan L, Yang B, Chen W, Gong Y, Xia B, Zhu H, Wu F, Wang Y, Dong L, Zhu Y, Pan J, Yao X, Dong B.
Du X, et al. Among authors: dong b, dong l, dong y.
Transl Oncol. 2023 Aug;34:101701. doi: 10.1016/j.tranon.2023.101701. Epub 2023 May 27.
Transl Oncol. 2023.
PMID: 37247504
Free PMC article.